Step Pharma will set up an insurance company with its subsidiaries

[chinapharma.com news] Shandong step Pharmaceutical Co., Ltd announced recently that it will set up an insurance company jointly with its subsidiaries The reporter learned that Shandong step Pharmaceutical Co., Ltd and its subsidiary Shaanxi step Pharmaceutical Co., Ltd (hereinafter referred to as "Shaanxi step") will respectively contribute 300 million yuan to subscribe 15% equity of Jilin Life Insurance Co., Ltd (hereinafter referred to as "Jilin life") Data shows that Jilin life's total registered capital is 2 billion yuan (picture source: Baidu picture) however, there is a business conflict between the company and another company under the name of Zhao Tao, its actual controller According to the announcement, Xianyang changtao Electronic Technology Co., Ltd (hereinafter referred to as "Xianyang changtao electronic") jointly controlled by Zhao Tao and its associated natural persons is currently participating in the establishment of Bai'an online Property Insurance Co., Ltd (hereinafter referred to as "Bai'an online property insurance"), and Xianyang changtao electronic intends to hold 6.34% of the shares of Bai'an online property insurance, existing with Jilin Life Insurance Co., Ltd established this time Potential industry competition In order to solve the problem of potential horizontal competition, Xianyang changtao electronic promised that within 90 working days after the approval of Insurance Regulatory Commission and the completion of industrial and commercial registration of Bai'an online property insurance, Xianyang changtao electronic would transfer all 6.34% shares of Bai'an online property insurance to an independent third party, and perform the procedures of government approval and Company review according to law to eliminate horizontal competition In fact, step pharmaceutical just received the "good" news about medical insurance recently According to the reporter, in the new medical insurance catalog released by the state recently, step pharmaceutical and its subsidiaries have 8 new products, including Shenxian Shengmai oral liquid, YangZheng mixture, Longshengzhi capsule, etc., and 3 products have withdrawn from the national medical insurance catalog Although it is impossible to judge the value of the products included in the medical insurance for the company in the short term, some optimistic companies believe that being included in the catalogue will be conducive to improving the sales and promotion of the products and have a positive impact In addition to the national medical insurance, many pharmaceutical enterprises are eager to get involved in commercial insurance According to the public information, there are many listed pharmaceutical companies in China, including Kangmei pharmaceutical, Fosun Pharmaceutical, hisilico, etc., involved in insurance companies.